E-LIB Suche - Ergebnisse für: P. SESQUES

1

PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER A..:

Sesques, P. ; Di blasi, R. ; Legouill, S....
Hematological Oncology. 41 (2023) S2 - p. 202-204 , 2023

Link: https://doi.org/10.1002/..

2

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PRE..:

Camus, V. ; Viailly, P. ; Sesques, P....
Hematological Oncology. 41 (2023) S2 - p. 110-111 , 2023

Link: https://doi.org/10.1002/..

3

S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-H..:

SESQUES, P. ; DI BLASI, R. ; LE GOUILL, S....
HemaSphere. 6 (2022) - p. 111-112 , 2022

Link: https://doi.org/10.1097/..

4

S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTA..:

Bachy, E. ; Le Gouill, S. ; Sesques, P....
HemaSphere. 6 (2022) - p. 161-162 , 2022

Link: https://doi.org/10.1097/..

5

CAR‐HEMATOTOX: A DISCRIMINATIVE MODEL FOR CAR T‐CELL RELATE..:

Rejeski, K. ; Perez, A. ; Sesques, P....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

FIRST RESULTS OF DLBCL PATIENTS TREATED WITH CAR‐T CELLS AN..:

Le Gouill, S. ; Bachy, E. ; Di Blasi, R....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY ME..:

Camus, V. ; Rossi, C. ; Sesques, P....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

Suivi prospectif infectiologique d'une cohorte de 75 receve..:

Neyret, E. ; Sesques, P. ; Ferrant, E....
Médecine et Maladies Infectieuses. 50 (2020) 6 - p. S120-S121 , 2020

Link: https://doi.org/10.1016/..

9

REAL‐WORLD RESULTS ON CD19 CAR T‐CELL FOR 60 FRENCH PATIENT..:

Thieblemont, C. ; Le Gouill, S. ; Di Blasi, R....
Hematological Oncology. 37 (2019) S2 - p. 301-301 , 2019

Link: https://doi.org/10.1002/..

10

JS1.4 Neurological follow-up of neurotoxicity after CAR T c..:

Belin, C ; Simard, C ; Dos Santos, A...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii5-iii5 , 2019

Link: https://doi.org/10.1093/..

11

CHARACTERISTICS AND OUTCOMES OF RELAPSED FOLLICULAR LYMPHOM..:

Sesques, P. ; Golfier, C. ; Boursier, J....
Hematological Oncology. 35 (2017) S2 - p. 220-221 , 2017

Link: https://doi.org/10.1002/..

12

First-line treatment of double- and triple-hit lymphomas: S..:

Laude, M. C ; Lebras, L ; Sesques, P...
10.1002/ajh.26068. , 2023

Link: https://hdl.handle.net/2..

13

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
10.1038/s41591-022-01969-y. , 2023

Link: https://hdl.handle.net/2..

14

S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-H..:

P. SESQUES ; R. DI BLASI ; S. LE GOUILL...
http://journals.lww.com/10.1097/01.HS9.0000843732.68211.6c. , 2022

Link: https://doi.org/10.1097/..

15

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-022-01969-y. , 2022

Link: https://hal.univ-lille.f..